Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05243797
Title A Study of Teclistamab in Combination With Lenalidomide Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation (MajesTEC-4)
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Myeloma Network

multiple myeloma



Lenalidomide + Teclistamab

Age Groups: adult | senior
Covered Countries ITA | DEU | BEL | AUT

No variant requirements are available.